http://www.depictproject.org/ One of the objectives of DEPICT Project is to build an extensive database of RCTs and Systematic Reviews published regarding clinical pharmacy services. If you want to see our updated list of references, please visit our Mendeley Group at: http://www.mendeley.com/groups/2926701/depict-project/

1. RCTs REFERENCES
1. Klein A, Otto G, Krämer I. Impact of a pharmaceutical care program on liver transplant
patients’ compliance with immunosuppressive medication: a prospective, randomized,
controlled trial using electronic monitoring. Transplantation. 2009 Mar 27;87(6):839–47.
2. Nietert PJ, Tilley BC, Zhao W, Edwards PF, Wessell AM, Mauldin PD, et al. Two pharmacy
interventions to improve refill persistence for chronic disease medications: a randomized,
controlled trial. Medical care. 2009 Jan;47(1):32–40.
3. Elnour a a, El Mugammar IT, Jaber T, Revel T, McElnay JC. Pharmaceutical care of patients
with gestational diabetes mellitus. Journal of evaluation in clinical practice. 2008
Feb;14(1):131–40.
4. Lalonde L, Martineau J, Blais N, Montigny M, Ginsberg J, Fournier M, et al. Is long-term
pharmacist-managed anticoagulation service efficient? A pragmatic randomized controlled
trial. American heart journal. 2008 Jul;156(1):148–54.
5. Schneider PJ, Murphy JE, Pedersen CA. Impact of medication packaging on adherence and
treatment outcomes in older ambulatory patients. Journal of the American Pharmacists
Association : JAPhA. 2008;48(1):58–63.
6. Phumipamorn S, Pongwecharak J, Soorapan S, Pattharachayakul S. Effects of the pharmacist’s
input on glycaemic control and cardiovascular risks in Muslim diabetes. Primary care diabetes.
2008 Feb;2(1):31–7.
7. Carter BL, Bergus GR, Dawson JD, Farris KB, Doucette WR, Chrischilles E a, et al. A cluster
randomized trial to evaluate physician/pharmacist collaboration to improve blood pressure
control. Journal of clinical hypertension (Greenwich, Conn.). 2008 Apr;10(4):260–71.
8. McLean DL, McAlister FA, Johnson JA, King KM, Makowsky MJ, Jones CA, et al. A
randomized trial of the effect of community pharmacist and nurse care on improving blood
pressure management in patients with diabetes mellitus: study of cardiovascular risk
intervention by pharmacists-hypertension (SCRIP-HTN). Archives of internal medicine. 2008
Nov 24;168(21):2355–61.
9. Green BB, Cook AJ, Ralston JD, Fishman PA, Catz SL, Carlson J, et al. Effectiveness of home
blood pressure monitoring, Web communication, and pharmacist care on hypertension control:
a randomized controlled trial. JAMA : the journal of the American Medical Association. 2008
Jun 25;299(24):2857–67.
10. Elliott RA, Barber N, Clifford S, Horne R, Hartley E. The cost effectiveness of a telephone-
based pharmacy advisory service to improve adherence to newly prescribed medicines.
Pharmacy world & science : PWS. 2008 Jan;30(1):17–23.
11. Reeve JF, Tenni PC, Peterson GM. An electronic prompt in dispensing software to promote
clinical interventions by community pharmacists: a randomized controlled trial. British journal
of clinical pharmacology. 2008 Mar;65(3):377–85.
12. Hunt JS, Siemienczuk J, Pape G, Rozenfeld Y, MacKay J, LeBlanc BH, et al. A randomized
controlled trial of team-based care: impact of physician-pharmacist collaboration on
uncontrolled hypertension. Journal of general internal medicine. 2008 Dec;23(12):1966–72.
13. Community Pharmacy Medicines Management Project Evaluation Team. The MEDMAN
study: a randomized controlled trial of community pharmacy-led medicines management for
patients with coronary heart disease. Family practice. 2007 Apr;24(2):189–200.
14. Raebel MA, Charles J, Dugan J, Carroll NM, Korner EJ, Brand DW, et al. Randomized trial to
improve prescribing safety in ambulatory elderly patients. Journal of the American Geriatrics
Society. 2007 Jul;55(7):977–85.
15. Nagavi B, Adepu R, Rasheed a, Adepu R et al. Effect of patient counseling on quality of life in
type-2 diabetes mellitus patients in two selected South Indian community pharmacies: A study.
Indian Journal of Pharmaceutical Sciences. 2007;69(4):519.
16. Krass I, Armour CL, Mitchell B, Brillant M, Dienaar R, Hughes J, et al. The Pharmacy
Diabetes Care Program: assessment of a community pharmacy diabetes service model in
Australia. Diabetic medicine : a journal of the British Diabetic Association. 2007
Jun;24(6):677–83.
17. Murray MDMD, Young J, Hoke S, Tu W, Weiner M, Morrow D, et al. Pharmacist intervention
to improve medication adherence in heart failure: a randomized trial. Annals of internal
medicine. Am Coll Physicians; 2007 May 15;146(10):714–25.
18. De Geest S, Schäfer-Keller P, Denhaerynck K, Thannberger N, Köfer S, Bock A, et al.

2. Supporting medication adherence in renal transplantation (SMART): a pilot RCT to improve
adherence to immunosuppressive regimens. Clinical transplantation. 2007;20(3):359–68.
19. Raebel MA, Carroll NM, Kelleher JA, Chester EA, Berga S, Magid DJ. Randomized trial to
improve prescribing safety during pregnancy. Journal of the American Medical Informatics
Association : JAMIA. 2007;14(4):440–50.
20. Lenaghan E, Holland R, Brooks A. Home-based medication review in a high risk elderly
population in primary care--the POLYMED randomised controlled trial. Age and ageing. 2007
May;36(3):292–7.
21. Holland R, Brooksby I, Lenaghan E, Ashton K, Hay L, Smith R, et al. Effectiveness of visits
from community pharmacists for patients with heart failure: HeartMed randomised controlled
trial. BMJ (Clinical research ed.). 2007/04/25 ed. 2007 May 26;334(7603):1098.
22. Bailey TC, Noirot LA, Blickensderfer A, Rachmiel E, Schaiff R, Kessels A, et al. An
intervention to improve secondary prevention of coronary heart disease. Archives of internal
medicine. 2007 Mar 26;167(6):586–90.
23. Tinelli M, Bond C, Blenkinsopp A, Jaffray M, Watson M, Hannaford P. Patient evaluation of a
community pharmacy medications management service. The Annals of pharmacotherapy. 2007
Dec;41(12):1962–70.
24. McLean DL. Nurses managing high blood pressure in patients with diabetes in community
pharmacies. Canadian journal of cardiovascular nursing. 2007 Jan;17(2):17–21.
25. Chan FWH, Wong RSM, Lau W-H, Chan TYK, Cheng G, You JHS. Management of Chinese
patients on warfarin therapy in two models of anticoagulation service - a prospective
randomized trial. British journal of clinical pharmacology. 2006 Nov;62(5):601–9.
26. Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence
and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized
controlled trial. JAMA : the journal of the American Medical Association. 2006 Dec
6;296(21):2563–71.
27. McLean DL, FA M, JA J, KM K, CA J, RT T. Improving blood pressure management in
patients with diabetes: the design of the SCRIP-HTN study. Can Pharm J. 2006;139:36–9.
28. Vrijens B, Belmans A, Matthys K, De Klerk E, Lesaffre E. Effect of intervention through a
pharmaceutical care program on patient adherence with prescribed once-daily atorvastatin.
Pharmacoepidemiology and drug safety. 2006 Feb;15(2):115–21.
29. Scott DM, Boyd ST, Stephan M, Augustine SC, Reardon TP. Outcomes of pharmacist-
managed diabetes care services in a community health center. American journal of health-
system pharmacy : AJHP : official journal of the American Society of Health-System
Pharmacists. 2006 Nov 1;63(21):2116–22.
30. Zermansky AGAG, Alldred DPDP, Petty DRDR, Raynor DKDK, Freemantle N, Eastaugh J, et
al. Clinical medication review by a pharmacist of elderly people living in care homes--
randomised controlled trial. Age and ageing. Br Geriatrics Soc; 2006 Nov;35(6):586–91.
31. Fornos JAJA, Andrés NFF, Andrés JCC, Guerra MMM, Egea B. a pharmacotherapy follow-up
program in patients with type-2 diabetes in community pharmacies in spain. Pharmacy world &
science. Springer; 2006 Apr;28(2):65–72.
32. Clifford S, Barber N, Elliott R, Hartley E, Horne R. Patient-centred advice is effective in
improving adherence to medicines. Pharmacy world & science : PWS. 2006 Jun;28(3):165–70.
33. Rehring TF, Stolcpart RS, Sandhoff BG, Merenich JA, Hollis HW. Effect of a clinical
pharmacy service on lipid control in patients with peripheral arterial disease. Journal of
vascular surgery : official publication, the Society for Vascular Surgery [and] International
Society for Cardiovascular Surgery, North American Chapter. 2006 Jun;43(6):1205–10.
34. Raebel MA, Chester EA, Newsom EE, Lyons EE, Kelleher JA, Long C, et al. Randomized trial
to improve laboratory safety monitoring of ongoing drug therapy in ambulatory patients.
Pharmacotherapy. 2006 May;26(5):619–26.
35. De Castro MS, Fuchs FD, Santos MC, Maximiliano P, Gus M, Moreira LB, et al.
Pharmaceutical care program for patients with uncontrolled hypertension. Report of a double-
blind clinical trial with ambulatory blood pressure monitoring. American journal of
hypertension. 2006 May;19(5):528–33.
36. Beaucage K, Lachance-Demers H, Ngo TT, Vachon C, Lamarre D, Guévin J-F, et al.
Telephone follow-up of patients receiving antibiotic prescriptions from community pharmacies.
American journal of health-system pharmacy : AJHP : official journal of the American Society
of Health-System Pharmacists. 2006 Mar 15;63(6):557–63.
37. Hennessy S, Leonard CE, Yang W, Kimmel SE, Townsend RR, Wasserstein AG, et al.
Effectiveness of a two-part educational intervention to improve hypertension control: a cluster-

3. randomized trial. Pharmacotherapy. 2006 Sep;26(9):1342–7.
38. Schnipper JL, Kirwin JL, Cotugno MC, Wahlstrom SA, Brown BA, Tarvin E, et al. Role of
pharmacist counseling in preventing adverse drug events after hospitalization. Archives of
internal medicine. 2006 Mar 13;166(5):565–71.
39. López Cabezas C, Falces Salvador C, Cubí Quadrada D, Arnau Bartés A, Ylla Boré M, Muro
Perea N, et al. Randomized clinical trial of a postdischarge pharmaceutical care program vs
regular follow-up in patients with heart failure. Farmacia hospitalaria : órgano oficial de
expresión científica de la Sociedad Española de Farmacia Hospitalaria. Elsevier;
2006;30(6):328–42.
40. Rickles NM, Svarstad BL, Statz-Paynter JL, Taylor L V, Kobak KA. Improving patient
feedback about and outcomes with antidepressant treatment: a study in eight community
pharmacies. Journal of the American Pharmacists Association : JAPhA. 2006;46(1):25–32.
41. Bailey TC, Noirot LA, Gage BF, Li X, Shannon WD, Waterman B, et al. Improving adherence
to coronary heart disease secondary prevention medication guidelines at a community hospital.
AMIA ... Annual Symposium proceedings / AMIA Symposium. AMIA Symposium. 2006
Jan;850.
42. Wu JYF, Leung WYS, Chang S, Lee B, Zee B, Tong PCY, et al. Effectiveness of telephone
counselling by a pharmacist in reducing mortality in patients receiving polypharmacy:
randomised controlled trial. BMJ (Clinical research ed.). 2006 Sep 9;333(7567):522.
43. Rothman RLRL, So SASA, Shin J, Malone RMRM, Bryant B, DeWalt DADA, et al. Labor
characteristics and program costs of a successful diabetes disease management program.
American Journal of Managed Care. MWC MEDICAL WORLD COMMUNNICATIONS,
INC; 2006 May;12(5):277.
44. Davis TM, Clifford RM, Davis WA, Batty KT. The role of pharmaceutical care in diabetes
management. The British Journal of Diabetes & Vascular Disease. 2005 Nov 1;5(6):352–6.
45. Zillich AJAJ, Sutherland JMJM, Kumbera PAPA, Carter BLBL. Hypertension outcomes
through blood pressure monitoring and evaluation by pharmacists (HOME study). Journal of
general internal medicine. Wiley Online Library; 2005 Dec;20(12):1091–6.
46. Odegard PS, Goo A, Hummel J, Williams KL, Gray SL. Caring for poorly controlled diabetes
mellitus: a randomized pharmacist intervention. The Annals of pharmacotherapy. 2005
Mar;39(3):433–40.
47. Rickles NM, Svarstad BL, Statz-Paynter JL, Taylor L V, Kobak KA. Pharmacist
telemonitoring of antidepressant use: effects on pharmacist-patient collaboration. Journal of the
American Pharmacists Association : JAPhA. 2005;45(3):344–53.
48. Rathbun RC, Farmer KC, Stephens JR, Lockhart SM. Impact of an adherence clinic on
behavioral outcomes and virologic response in treatment of HIV infection: a prospective,
randomized, controlled pilot study. Clinical therapeutics. 2005 Feb;27(2):199–209.
49. Clifford RM, Davis W a, Batty KT, Davis TME. Effect of a pharmaceutical care program on
vascular risk factors in type 2 diabetes: the Fremantle Diabetes Study. Diabetes care. 2005
Apr;28(4):771–6.
50. Tierney WM, Overhage JM, Murray MD, Harris LE, Zhou X-H, Eckert GJ, et al. Can
computer-generated evidence-based care suggestions enhance evidence-based management of
asthma and chronic obstructive pulmonary disease? A randomized, controlled trial. Health
services research. 2005 Apr;40(2):477–97.
51. Al-Saffar N, Deshmukh a. a., Carter P, Adib SM. Effect of information leaflets and counselling
on antidepressant adherence: open randomised controlled trial in a psychiatric hospital in
Kuwait. International Journal of Pharmacy Practice. 2005 Jun 1;13(2):123–32.
52. Nickerson A, MacKinnon NJ, Roberts N, Saulnier L. Drug-therapy problems, inconsistencies
and omissions identified during a medication reconciliation and seamless care service.
Healthcare quarterly (Toronto, Ont.). 2005 Jan;8 Spec No:65–72.
53. Rothman RL, Malone R, Bryant B, Shintani AK, Crigler B, Dewalt DA, et al. A randomized
trial of a primary care-based disease management program to improve cardiovascular risk
factors and glycated hemoglobin levels in patients with diabetes. The American journal of
medicine. 2005 Mar;118(3):276–84.
54. Raebel MA, Lyons EE, Chester EA, Bodily MA, Kelleher JA, Long CL, et al. Improving
laboratory monitoring at initiation of drug therapy in ambulatory care: a randomized trial.
Archives of internal medicine. 2005 Nov 14;165(20):2395–401.
55. Paulós CP, Nygren CEA, Celedón C, Cárcamo C a. Impact of a pharmaceutical care program
in a community pharmacy on patients with dyslipidemia. The Annals of pharmacotherapy.
2005 May;39(5):939–43.

4. 56. Rothman RL et al. A pharmacist-driven intervention improves diabetes care. J Clin Outcomes
Manag. 2005;12:188– 189.
57. Suppapitiporn S, Chindavijak B, Onsanit S. Effect of diabetes drug counseling by pharmacist,
diabetic disease booklet and special medication containers on glycemic control of type 2
diabetes mellitus: a randomized controlled trial. Journal of the Medical Association of Thailand
= Chotmaihet thangphaet. 2005 Sep;88 Suppl 4(Suppl 4):S134–41.
58. Shane-McWhorter L, Oderda GM. Providing diabetes education and care to underserved
patients in a collaborative practice at a utah community health center. Pharmacotherapy. 2005
Jan;25(1):96–109.
59. Stuurman-Bieze AGG, Kokenberg MEAP, Tobi H, De Boer WO, Van Doormaal JE, Jong-van
den de Berg LTW, et al. Complex pharmaceutical care intervention in pulmonary care: part B.
Patient opinion and process survey. Pharmacy world & science : PWS. 2005 Oct;27(5):385–92.
60. Brook OH, Van Hout H, Stalman W, Nieuwenhuyse H, Bakker B, Heerdink E, et al. A
pharmacy-based coaching program to improve adherence to antidepressant treatment among
primary care patients. Psychiatric services (Washington, D.C.). 2005 Apr;56(4):487–9.
61. Jellinek SP et al. Analyzing a health-system’s use of unfractionated heparin to ensure optimal
anticoagulation. J Pharm Technol. 2005;21:69–78.
62. Sadik A, Yousif M, McElnay JC. Pharmaceutical care of patients with heart failure. British
journal of clinical pharmacology. 2005 Aug;60(2):183–93.
63. Choe HM, Mitrovich S, Dubay D, Hayward RA, Krein SL, Vijan S. Proactive case
management of high-risk patients with type 2 diabetes mellitus by a clinical pharmacist: a
randomized controlled trial. The American journal of managed care. 2005 Apr;11(4):253–60.
64. Holland R, Lenaghan E, Harvey I, Smith R, Shepstone L, Lipp A, et al. Does home based
medication review keep older people out of hospital? The HOMER randomised controlled trial.
BMJ (Clinical research ed.). 2005 Feb 5;330(7486):293.
65. Sarkadi A, Vég A, Rosenqvist U. The influence of participant’s self-perceived role on
metabolic outcomes in a diabetes group education program. Patient education and counseling.
2005 Aug;58(2):137–45.
66. Reid F, Murray P, Storrie M. Implementation of a pharmacist-led clinic for hypertensive
patients in primary care--a pilot study. Pharmacy world & science : PWS. 2005 Jun;27(3):202–
7.
67. Crotty M, Rowett D, Spurling L, Giles LC, Phillips PA. Does the addition of a pharmacist
transition coordinator improve evidence-based medication management and health outcomes in
older adults moving from the hospital to a long-term care facility? Results of a randomized,
controlled trial. The American journal of geriatric pharmacotherapy. 2004 Dec;2(4):257–64.
68. Rothman RL et al. Diabetes disease management program is more effective for patients with
low literacy. J Clin Outcomes Manag. 2004;11(12):752–3.
69. Sookaneknun P, Richards RME, Sanguansermsri J, Teerasut C. Pharmacist involvement in
primary care improves hypertensive patient clinical outcomes. The Annals of
pharmacotherapy. 2004 Dec;38(12):2023–8.
70. Capoccia KL, Boudreau DM, Blough DK, Ellsworth AJ, Clark DR, Stevens NG, et al.
Randomized trial of pharmacist interventions to improve depression care and outcomes in
primary care. American journal of health-system pharmacy : AJHP : official journal of the
American Society of Health-System Pharmacists. 2004 Feb 15;61(4):364–72.
71. Lim WS, Low HN, Chan SP, Chen HN, Ding YY, Tan TL. Impact of a pharmacist consult
clinic on a hospital-based geriatric outpatient clinic in Singapore. Annals of the Academy of
Medicine, Singapore. 2004 Mar;33(2):220–7.
72. Williams ME, Pulliam CC, Hunter R, Johnson TM, Owens JE, Kincaid J, et al. The short-term
effect of interdisciplinary medication review on function and cost in ambulatory elderly people.
Journal of the American Geriatrics Society. 2004 Jan;52(1):93–8.
73. Voirol P, Kayser SR, Chang CY, Chang QL, Youmans SL. Impact of pharmacists’
interventions on the pediatric discharge medication process. The Annals of pharmacotherapy.
2004 Oct;38(10):1597–602.
74. Peterson GM, Fitzmaurice KD, Naunton M, Vial JH, Stewart K, Krum H. Impact of
pharmacist-conducted home visits on the outcomes of lipid-lowering drug therapy. Journal of
clinical pharmacy and therapeutics. 2004 Feb;29(1):23–30.
75. Adler D a, Bungay KM, Wilson IB, Pei Y, Supran S, Peckham E, et al. The impact of a
pharmacist intervention on 6-month outcomes in depressed primary care patients. General
hospital psychiatry. 2004 Jan;26(3):199–209.
76. Murray MD, Young JM, Morrow DG, Weiner M, Tu W, Hoke SC, et al. Methodology of an

5. ongoing, randomized, controlled trial to improve drug use for elderly patients with chronic
heart failure. The American journal of geriatric pharmacotherapy. 2004 Mar;2(1):53–65.
77. Simpson SH, Johnson JA, Biggs RS, Tsuyuki RT. Greater effect of enhanced pharmacist care
on cholesterol management in patients with diabetes mellitus: a planned subgroup analysis of
the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). Pharmacotherapy.
2004 Mar;24(3):389–94.
78. Crotty M, Halbert J, Rowett D, Giles L, Birks R, Williams H, et al. An outreach geriatric
medication advisory service in residential aged care: a randomised controlled trial of case
conferencing. Age and ageing. 2004 Nov;33(6):612–7.
79. Sarkadi A, Rosenqvist U. Experience-based group education in Type 2 diabetes: a randomised
controlled trial. Patient education and counseling. 2004 Jun;53(3):291–8.
80. Tsuyuki RT, Fradette M, Johnson J a., Bungard TJ, Eurich DT, Ashton T, et al. A multicenter
disease management program for hospitalized patients with heart failure. Journal of cardiac
failure. 2004 Dec;10(6):473–80.
81. Ponnusankar S, Surulivelrajan M, Anandamoorthy N, Suresh B. Assessment of impact of
medication counseling on patients’ medication knowledge and compliance in an outpatient
clinic in South India. Patient education and counseling. 2004 Jul;54(1):55–60.
82. Crotty M, Whitehead C, Rowett D, Halbert J, Weller D, Finucane P, et al. An outreach
intervention to implement evidence based practice in residential care: a randomized controlled
trial [ISRCTN67855475]. BMC health services research. 2004 Apr 6;4(1):6.
83. Bolas H, Brookes K, Scott M, McElnay J. Evaluation of a hospital-based community liaison
pharmacy service in Northern Ireland. Pharmacy world & science : PWS. 2004 Apr;26(2):114–
20.
84. Sorensen L, Stokes JA, Purdie DM, Woodward M, Elliott R, Roberts MS. Medication reviews
in the community: results of a randomized, controlled effectiveness trial. British journal of
clinical pharmacology. 2004 Dec;58(6):648–64.
85. Bungay KM, Adler DA, Rogers WH, McCoy C, Kaszuba M, Supran S, et al. Description of a
clinical pharmacist intervention administered to primary care patients with depression. General
hospital psychiatry. 2004;26(3):210–8.
86. Murray MD, Harris LE, Overhage JM, Zhou X-H, Eckert GJ, Smith FE, et al. Failure of
computerized treatment suggestions to improve health outcomes of outpatients with
uncomplicated hypertension: results of a randomized controlled trial. Pharmacotherapy. 2004
Mar;24(3):324–37.
87. Graffen M, Kennedy D, Simpson M. Quality use of medicines in the rural ambulant elderly: a
pilot study. Rural and remote health. 2004;4(3):184.
88. Jackson SL, Peterson GM, Vial JH, Jupe DML. Improving the outcomes of anticoagulation: an
evaluation of home follow-up of warfarin initiation. Journal of internal medicine. 2004
Aug;256(2):137–44.
89. Bucci C, Jackevicius C, McFarlane K, Liu P. Pharmacist’s contribution in a heart function
clinic: patient perception and medication appropriateness. The Canadian journal of cardiology.
2003 Mar 31;19(4):391–6.
90. Tierney WM, Overhage JM, Murray MD, Harris LE, Zhou X-H, Eckert GJ, et al. Effects of
computerized guidelines for managing heart disease in primary care. Journal of general internal
medicine. 2003 Dec;18(12):967–76.
91. Finley PR, Rens HR, Pont JT, Gess SL, Louie C, Bull SA, et al. Impact of a collaborative care
model on depression in a primary care setting: a randomized controlled trial. Pharmacotherapy.
2003 Sep;23(9):1175–85.
92. Sturgess IK, McElnay JC, Hughes CM, Crealey G. Community pharmacy based provision of
pharmaceutical care to older patients. Pharmacy world & science : PWS. 2003 Oct;25(5):218–
26.
93. Sellors J, Kaczorowski J, Sellors C, Dolovich L, Woodward C, Willan A, et al. A randomized
controlled trial of a pharmacist consultation program for family physicians and their elderly
patients. CMAJ : Canadian Medical Association journal = journal de l’Association medicale
canadienne. 2003 Jul 8;169(1):17–22.
94. Hoffman L, Enders J, Luo J, Segal R, Pippins J, Kimberlin C. Impact of an antidepressant
management program on medication adherence. The American journal of managed care. 2003
Jan;9(1):70–80.
95. Borenstein JE, Graber G, Saltiel E, Wallace J, Ryu S, Archi J, et al. Physician-pharmacist
comanagement of hypertension: a randomized, comparative trial. Pharmacotherapy. 2003
Feb;23(2):209–16.

6. 96. Chabot I, Moisan J, Grégoire J-P, Milot A. Pharmacist intervention program for control of
hypertension. The Annals of pharmacotherapy. 2003 Sep;37(9):1186–93.
97. Barbanel D, Eldridge S, Griffiths C. Can a self-management programme delivered by a
community pharmacist improve asthma control? A randomised trial. Thorax. 2003
Oct;58(10):851–4.
98. Brook O, Van Hout H, Nieuwenhuyse H, Heerdink E. Impact of coaching by community
pharmacists on drug attitude of depressive primary care patients and acceptability to patients; a
randomized controlled trial. European neuropsychopharmacology : the journal of the European
College of Neuropsychopharmacology. 2003 Jan;13(1):1–9.
99. Bouvy ML, Heerdink ER, Urquhart J, Grobbee DE, Hoes AW, Leufkens HGM, et al. Effect of
a pharmacist-led intervention on diuretic compliance in heart failure patients: a randomized
controlled study. Journal of cardiac failure. 2003 Oct;9(5):404–11.
100. Grant RW, Devita NG, Singer DE, Meigs JB. Improving adherence and reducing medication
discrepancies in patients with diabetes. The Annals of pharmacotherapy. 2003;37(7-8):962–9.
101. Naunton M PG. Evaluation of home-based follow-up of high-risk elderly patients discharged
from hospital. J Pharm Pract Res. 2003;33:176–82.
102. Brook OH, Van Hout HPJ, Nieuwenhuysea H, De Haan M. Effects of coaching by community
pharmacists on psychological symptoms of antidepressant users; a randomised controlled trial.
European neuropsychopharmacology : the journal of the European College of
Neuropsychopharmacology. 2003 Oct;13(5):347–54.
103. González-Martin G, Joo I, Sánchez I. Evaluation of the impact of a pharmaceutical care
program in children with asthma. Patient education and counseling. 2003 Jan;49(1):13–8.
104. Wilson SJ-A, Wells PS, Kovacs MJ, Lewis GM, Martin J, Burton E, et al. Comparing the
quality of oral anticoagulant management by anticoagulation clinics and by family physicians:
a randomized controlled trial. CMAJ : Canadian Medical Association journal = journal de
l’Association medicale canadienne. 2003 Aug 19;169(4):293–8.
105. Taylor CT, Byrd DC, Krueger K. Improving primary care in rural Alabama with a pharmacy
initiative. American journal of health-system pharmacy : AJHP : official journal of the
American Society of Health-System Pharmacists. 2003 Jun 1;60(11):1123–9.
106. Ahrens RA, Hower M, Best AM. Effects of weight reduction interventions by community
pharmacists. Journal of the American Pharmacists Association : JAPhA. 2003;43(5):583–9.
107. Clifford RM, Batty KT, Davis TME, Davis W, Stein G, Stewart G, et al. A randomised
controlled trial of a pharmaceutical care programme in high-risk diabetic patients in an
outpatient clinic. International Journal of Pharmacy Practice. 2002 Jun 22;10(2):85–9.
108. Stergachis A, Gardner JS, Anderson MT, Sullivan SD. Improving pediatric asthma outcomes in
the community setting: does pharmaceutical care make a difference? Journal of the American
Pharmaceutical Association (Washington,D.C. : 1996). 2002;42(5):743–52.
109. Zermansky AG, Petty DR, Raynor DK, Lowe CJ, Freemantle N, Vail A. Clinical medication
review by a pharmacist of patients on repeat prescriptions in general practice: a randomised
controlled trial. Health technology assessment (Winchester, England). 2002 Jan;6(20):1–86.
110. Raji A, Gomes H, Beard JO, MacDonald P, Conlin PR. A randomized trial comparing
intensive and passive education in patients with diabetes mellitus. Archives of internal
medicine. 2002 Jun 10;162(11):1301–4.
111. Tsuyuki RT, Johnson JA, Teo KK, Simpson SH, Ackman ML, Biggs RS, et al. A randomized
trial of the effect of community pharmacist intervention on cholesterol risk management: the
Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). Archives of internal
medicine. 2002 May 27;162(10):1149–55.
112. Practice EC, April M, Goodman MJ, Fischer LR, Defor TA, Cooper S, et al. Pharmaceutical
care and health care utilization in an HMO. Effective clinical practice : ECP. 2002;5(2):49–57.
113. Al-Rashed SA, Wright DJ, Roebuck N, Sunter W, Chrystyn H. The value of inpatient
pharmaceutical counselling to elderly patients prior to discharge. British journal of clinical
pharmacology. 2002 Dec;54(6):657–64.
114. Bultman DC, Svarstad BL. Effects of pharmacist monitoring on patient satisfaction with
antidepressant medication therapy. Journal of the American Pharmaceutical Association
(Washington,D.C. : 1996). 2002;42(1):36–43.
115. Weinberger M, Murray MD, Marrero DG, Brewer N, Lykens M, Harris LE, et al. Effectiveness
of pharmacist care for patients with reactive airways disease: a randomized controlled trial.
JAMA : the journal of the American Medical Association. 2002 Oct 2;288(13):1594–602.
116. Scarsi KK, Fotis MA, Noskin GA. Pharmacist participation in medical rounds reduces
medication errors. American journal of health-system pharmacy : AJHP : official journal of the

7. American Society of Health-System Pharmacists. 2002 Nov 1;59(21):2089–92.
117. Chuc NTK, Larsson M, Do NT, Diwan VK, Tomson GB, Falkenberg T. Improving private
pharmacy practice: a multi-intervention experiment in Hanoi, Vietnam. Journal of clinical
epidemiology. 2002 Nov;55(11):1148–55.
118. Vivian EM. Improving blood pressure control in a pharmacist-managed hypertension clinic.
Pharmacotherapy. 2002 Dec;22(12):1533–40.
119. Geber J, Parra D, Beckey NP, Korman L. Optimizing drug therapy in patients with
cardiovascular disease: the impact of pharmacist-managed pharmacotherapy clinics in a
primary care setting. Pharmacotherapy. 2002 Jun;22(6):738–47.
120. Chisholm MA, Mulloy LL, Jagadeesan M, Martin BC, DiPiro JT. Effect of clinical pharmacy
services on the blood pressure of African-American renal transplant patients. Ethnicity &
disease. 2002 Jan;12(3):392–7.
121. Freemantle N, Nazareth I, Eccles M, Wood J, Haines A. A randomised controlled trial of the
effect of educational outreach by community pharmacists on prescribing in UK general
practice. The British journal of general practice : the journal of the Royal College of General
Practitioners. 2002 Apr;52(477):290–5.
122. Stevens VJ, Shneidman RJ, Johnson RE, Boles M, Steele PE, Lee NL. Helicobacter pylori
eradication in dyspeptic primary care patients: a randomized controlled trial of a pharmacy
intervention. The Western journal of medicine. 2002 Mar;176(2):92–6.
123. Al-Eidan FA, McElnay JC, Scott MG, McConnell JB. Management of Helicobacter pylori
eradication--the influence of structured counselling and follow-up. British journal of clinical
pharmacology. 2002 Feb;53(2):163–71.
124. Hirsch IB, Goldberg HI, Ellsworth A, Evans TC, Herter CD, Ramsey SD, et al. A multifaceted
intervention in support of diabetes treatment guidelines: a cont trial. Diabetes research and
clinical practice. 2002 Oct;58(1):27–36.
125. Stowasser DA, Collins DM SM. A randomised controlled trial of medication liaison services –
patient outcomes. J Pharm Prac Res. 2002;32:133–40.
126. Garção JA, Cabrita J. Evaluation of a pharmaceutical care program for hypertensive patients in
rural Portugal. Journal of the American Pharmaceutical Association (Washington,D.C. : 1996).
2002;42(6):858–64.
127. Meredith S, Feldman P, Frey D, Giammarco L, Hall K, Arnold K, et al. Improving medication
use in newly admitted home healthcare patients: a randomized controlled trial. Journal of the
American Geriatrics Society. 2002 Sep;50(9):1484–91.
128. Cordina M, McElnay JC, Hughes CM. Assessment of a community pharmacy-based program
for patients with asthma. Pharmacotherapy. 2001 Oct;21(10):1196–203.
129. Malone DCC, Carter BLL, Billups SJJ, Valuck RJJ, Barnette DJJ, Sintek CDD, et al. Can
clinical pharmacists affect SF-36 scores in veterans at high risk for medication-related
problems? Medical care. 2001 Feb;39(2):113–22.
130. Allard J, Hébert R, Rioux M, Asselin J, Voyer L. Efficacy of a clinical medication review on
the number of potentially inappropriate prescriptions prescribed for community-dwelling
elderly people. CMAJ : Canadian Medical Association journal = journal de l’Association
medicale canadienne. 2001 May 1;164(9):1291–6.
131. Zermansky AGG, Petty DRR, Raynor DKK, Freemantle N, Vail A, Lowe CJJ. Randomised
controlled trial of clinical medication review by a pharmacist of elderly patients receiving
repeat prescriptions in general practice. BMJ (Clinical research ed.). British Medical Journal
Publishing Group; 2001 Dec 8;323(7325):1340–3.
132. Volume CI, Farris KB, Kassam R, Cox CE, Cave A. Pharmaceutical care research and
education project: patient outcomes. Journal of the American Pharmaceutical Association
(Washington,D.C. : 1996). 2001;41(3):411–20.
133. Chisholm MA, Mulloy LL, Jagadeesan M, DiPiro JT. Impact of clinical pharmacy services on
renal transplant patients’ compliance with immunosuppressive medications. Clinical
transplantation. 2001 Oct;15(5):330–6.
134. Herborg H, Soendergaard B, Froekjaer B, Fonnesbaek L, Jorgensen T, Hepler CD, et al.
Improving drug therapy for patients with asthma--part 1: Patient outcomes. Journal of the
American Pharmaceutical Association (Washington,D.C. : 1996). 2001;41(4):539–50.
135. Barenfanger J, Short MA, Groesch AA. Improved antimicrobial interventions have benefits.
Journal of clinical microbiology. 2001 Aug;39(8):2823–8.
136. Nazareth I, Burton A, Shulman S, Smith P, Haines A, Timberal H. A pharmacy discharge plan
for hospitalized elderly patients--a randomized controlled trial. Age and ageing. 2001
Jan;30(1):33–40.

8. 137. Hall L, Eccles M, Barton R, Steen N, Campbell M. Is untargeted outreach visiting in primary
care effective? A pragmatic randomized controlled trial. Journal of public health medicine.
2001 Jun;23(2):109–13.
138. Dudas V, Bookwalter T, Kerr KM, Pantilat SZ. The impact of follow-up telephone calls to
patients after hospitalization. The American journal of medicine. 2001 Dec 21;111(9B):26S–
30S.
139. Kassam R, Farris KB, Burback L, Volume CI, Cox CE, Cave A. Pharmaceutical care research
and education project: pharmacists’ interventions. Journal of the American Pharmaceutical
Association (Washington,D.C. : 1996). 2001;41(3):401–10.
140. Watson M, Gunnell D, Peters T, Brookes S, Sharp D. Guidelines and educational outreach
visits from community pharmacists to improve prescribing in general practice: a randomised
controlled trial. Journal of health services research & policy. 2001 Oct;6(4):207–13.
141. Jameson JPP, VanNoord GRR. Pharmacotherapy consultation on polypharmacy patients in
ambulatory care. The Annals of pharmacotherapy. Harvey Whitney Books; 2001;35(7/8):835–
40.
142. Maguire T a, McElnay JC, Drummond a. A randomized controlled trial of a smoking cessation
intervention based in community pharmacies. Addiction (Abingdon, England). 2001
Feb;96(2):325–31.
143. Bynum A, Hopkins D, Thomas A, Copeland N, Irwin C. The effect of telepharmacy counseling
on metered-dose inhaler technique among adolescents with asthma in rural Arkansas.
Telemedicine journal and e-health : the official journal of the American Telemedicine
Association. 2001 Jan;7(3):207–17.
144. Guirguis LM, Johnson JA, Farris KB, Tsuyuki RT T EL. A pilot study to evaluate the role of
pharmacists as certified diabetes educators on the clinical and humanistic outcomes of people
with diabetes. Can J Diab Care. 2001;25:266–76.
145. Goldwater SH, Milkovich G, Morrison AJ, Lindgren B. Comparison of therapeutic interchange
with standard educational tools for influencing fluoroquinolone prescribing. American journal
of health-system pharmacy : AJHP : official journal of the American Society of Health-System
Pharmacists. 2001 Sep 15;58(18):1740–5.
146. Bernsten C, Björkman I, Caramona M, Crealey G, Frøkjaer B, Grundberger E, et al. Improving
the well-being of elderly patients via community pharmacy-based provision of pharmaceutical
care: a multicentre study in seven European countries. Drugs & aging. 2001 Jan;18(1):63–77.
147. Dranitsaris G, Spizzirri D, Pitre M, McGeer A. A randomized trial to measure the optimal role
of the pharmacist in promoting evidence-based antibiotic use in acute care hospitals.
International journal of technology assessment in health care. 2001 Jan;17(2):171–80.
148. Roberts MS, Stokes JA, King MA, Lynne TA, Purdie DM, Glasziou PP, et al. Outcomes of a
randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes. British
journal of clinical pharmacology. 2001 Mar;51(3):257–65.
149. Okamoto MP, Nakahiro RK. Pharmacoeconomic evaluation of a pharmacist-managed
hypertension clinic. Pharmacotherapy. 2001 Nov;21(11):1337–44.
150. Sellors C, Dalby DM, Howard M, Kaczorowski J SJ. A pharmacist consultation service in
community-based family practices: a randomized, controlled trial in seniors. J Pharm Technol.
2001;17:264–9.
151. Krska J, Cromarty J a, Arris F, Jamieson D, Hansford D, Duffus PR, et al. Pharmacist-led
medication review in patients over 65: a randomized, controlled trial in primary care. Age and
ageing. 2001 May;30(3):205–11.
152. Grymonpre RE, Williamson DA MP, GRYMONPRE RER, WILLIAMSON DA,
MONTGOMERY PR. Impact of a pharmaceutical care model for non-institutionalised elderly:
results of a randomised, controlled trial. Int J Pharm Prac. 2001 Dec 22;9(9):235–41.
153. Van Eijk ME, Avorn J, Porsius AJ, De Boer A. Reducing prescribing of highly anticholinergic
antidepressants for elderly people: randomised trial of group versus individual academic
detailing. BMJ (Clinical research ed.). 2001 Mar 17;322(7287):654–7.
154. Ellis SL, Billups SJ, Malone DC, Carter BL, Covey D, Mason B, et al. Types of interventions
made by clinical pharmacists in the IMPROVE study. Pharmacotherapy. 2000 Apr;20(4):429–
35.
155. Ilett KF, Johnson S, Greenhill G, Mullen L, Brockis J, Golledge CL, et al. Modification of
general practitioner prescribing of antibiotics by use of a therapeutics adviser (academic
detailer). British journal of clinical pharmacology. 2000 Feb;49(2):168–73.
156. Lowe CJ, Raynor DK, Purvis J, Farrin a, Hudson J. Effects of a medicine review and education
programme for older people in general practice. British journal of clinical pharmacology. 2000

9. Aug;50(2):172–5.
157. Gammaitoni AR, Gallagher RM, Welz M, Gracely EJ, Knowlton CH, Voltis-Thomas O.
Palliative pharmaceutical care: a randomized, prospective study of telephone-based
prescription and medication counseling services for treating chronic pain. Pain medicine
(Malden, Mass.). 2000 Dec;1(4):317–31.
158. Lee KL, Peng YL, Chou JL, Lee KT, Chung HM. Economic evaluation of therapeutic drug
monitoring services in renal transplant recipients treated with cyclosporine. Transplantation
proceedings. 2000 Nov;32(7):1801–6.
159. Bond C, Matheson C, Williams S, Williams P, Donnan P. Repeat prescribing: a role for
community pharmacists in controlling and monitoring repeat prescriptions. The British journal
of general practice : the journal of the Royal College of General Practitioners. 2000/07/18 ed.
2000 Apr;50(453):271–5.
160. Mehos BM, Saseen JJ, MacLaughlin EJ. Effect of pharmacist intervention and initiation of
home blood pressure monitoring in patients with uncontrolled hypertension. Pharmacotherapy.
2000 Nov;20(11):1384–9.
161. Faulkner MA, Wadibia EC, Lucas BD, Hilleman DE. Impact of pharmacy counseling on
compliance and effectiveness of combination lipid-lowering therapy in patients undergoing
coronary artery revascularization: a randomized, controlled trial. Pharmacotherapy. 2000
Apr;20(4):410–6.
162. Secnik K, Pathak DS, Cohen JM. Postcard and telephone reminders for unclaimed
prescriptions: a comparative evaluation using survival analysis. Journal of the American
Pharmaceutical Association (Washington,D.C. : 1996). 2000;40(2):243–51; quiz 330–1.
163. Barnett CW, Nykamp D, Ellington a M. Patient-guided counseling in the community pharmacy
setting. Journal of the American Pharmaceutical Association (Washington,D.C. : 1996).
2000;40(6):765–72.
164. Shaw H, Mackie CA SI. Evaluation of effect of pharmacy discharge planning on medication
problems experienced by discharged acute admission mental health patients. International
Journal of Pharmacy Practice. 2000;8:144–53.
165. BLENKINSOPP A, Phelan M, BOURNE J, DAKHIL N, Blenkinsopp A, Phelan M, Bourne J
et al., Blekinsopp A. Extended adherence support by community pharmacists for patients with
hypertension: a randomised controlled trial. International Journal of Pharmacy Practice. 2000
Sep 22;8(sept):165–75.
166. Furniss L, Burns A, Craig SK, Scobie S, Cooke J, Faragher B. Effects of a pharmacist’s
medication review in nursing homes. Randomised controlled trial. The British journal of
psychiatry : the journal of mental science. 2000 Jun;176:563–7.
167. Nola KM, Gourley DRR, Portner TSS, Gourley GKK, Solomon DKK, Elam M, et al. Clinical
and humanistic outcomes of a lipid management program in the community pharmacy setting.
Journal of the American Pharmaceutical Association (Washington,D.C. : 1996).
2000;40(2):166–73.
168. Burns A, Furniss L, Cooke J, Lloyd Craig SK SS. Pharmacist medication review in nursing
homes: a cost analysis. International Journal of Geriatric Psychopharmacology. 2000;2:137–41.
169. Turner CJ, Parfrey P, Ryan K, Miller R, Brown A. Community pharmacist outreach program
directed at physicians treating congestive heart failure. American journal of health-system
pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
2000 Apr 15;57(8):747–52.
170. Ellis SL, Carter BL, Malone DC, Billups SJ, Okano GJ, Valuck RJ, et al. Clinical and
economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in
older adults: the IMPROVE study. Impact of Managed Pharmaceutical Care on Resource
Utilization and Outcomes in Veterans Affairs Medical Centers. Pharmacotherapy. 2000
Dec;20(12):1508–16.
171. Malone DC, Carter BL, Billups SJ, Valuck RJ, Barnette DJ, Sintek CD, et al. An economic
analysis of a randomized, controlled, multicenter study of clinical pharmacist interventions for
high-risk veterans: the IMPROVE study. Impact of Managed Pharmaceutical Care Resource
Utilization and Outcomes in Veterans Affairs Medical Centers. Pharmacotherapy. 2000
Oct;20(10):1149–58.
172. Kelly C, Rodgers P. Implementation and evaluation of a pharmacist-managed diabetes service.
Journal of managed care pharmacy : JMCP. 2000;6(6):488–93.
173. Bozovich M, Rubino CM, Edmunds J. Effect of a clinical pharmacist-managed lipid clinic on
achieving National Cholesterol Education Program low-density lipoprotein goals.
Pharmacotherapy. 2000 Nov;20(11):1375–83.

10. 174. Schmidt IK, Fastbom J. Quality of Drug Use in Swedish Nursing Homes. Clinical Drug
Investigation. 2000 Dec;20(6):433–46.
175. McMullin ST, Hennenfent JA, Ritchie DJ, Huey WY, Lonergan TP, Schaiff RA, et al. A
prospective, randomized trial to assess the cost impact of pharmacist-initiated interventions.
Archives of internal medicine. 1999 Oct 25;159(19):2306–9.
176. Gums JG, Yancey RW, Hamilton CA, Kubilis PS. A randomized, prospective study measuring
outcomes after antibiotic therapy intervention by a multidisciplinary consult team.
Pharmacotherapy. 1999 Dec;19(12):1369–77.
177. Sadur CN, Moline N, Costa M, Michalik D, Mendlowitz D, Roller S, et al. Diabetes
management in a health maintenance organization. Efficacy of care management using cluster
visits. Diabetes care. 1999 Dec;22(12):2011–7.
178. Gattis WA, Hasselblad V, Whellan DJ, O’Connor CM. Reduction in heart failure events by the
addition of a clinical pharmacist to the heart failure management team: results of the
Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study.
Archives of internal medicine. 1999 Sep 13;159(16):1939–45.
179. Murray MD, Loos B, Tu W, Eckert GJ, Zhou XH, Tierney WM. Work patterns of ambulatory
care pharmacists with access to electronic guideline-based treatment suggestions. American
journal of health-system pharmacy : AJHP : official journal of the American Society of Health-
System Pharmacists. 1999 Feb 1;56(3):225–32.
180. Coleman EA, Grothaus LC, Sandhu N, Wagner EH. Chronic care clinics: a randomized
controlled trial of a new model of primary care for frail older adults. Journal of the American
Geriatrics Society. 1999 Jul;47(7):775–83.
181. Mackie CA, Lawson DH,Maclaren AG, Kaczorowski J SJ. A randomised controlled trial of
medication review in patients receiving polypharmacy in general practice. Pharm J.
1999;263((Suppl.): R7).
182. Cordina, M., McElnay, J. C. & Hughes CM. Assessing intervention and outcomes of a
pharmaceutical care programme directed at asthma patients. Pharmaceutical Journal.
1999;263((supl.)):R10.
183. Rainville EC. Impact of pharmacist interventions on hospital readmissions for heart failure.
American journal of health-system pharmacy : AJHP : official journal of the American Society
of Health-System Pharmacists. 1999 Jul 1;56(13):1339–42.
184. Granas AG BI, Granas, A. G. & Bates I. The effect of pharmaceutical review of repeat
prescriptions in general practice. Int J Pharm Pract. 1999;7:264–75.
185. Knobel H, Carmona A, López JL, Gimeno JL, Saballs P, González A, et al. [Adherence to very
active antiretroviral treatment: impact of individualized assessment]. Enfermedades infecciosas
y microbiología clínica. 1999 Feb;17(2):78–81.
186. Varma S, McElnay JC, Hughes CM, Passmore AP, Varma M. Pharmaceutical care of patients
with congestive heart failure: interventions and outcomes. Pharmacotherapy. 1999
Jul;19(7):860–9.
187. Chisholm MA, Reinhardt BO, Vollenweider LJ, Martin BC, DiPiro JT et al. Effect of
pharmaceutical care services on renal transplant patients’ blood glucose levels. Poster
presented at: ASHP Midyear Clinical Meeting. 1999. p. P–148E.
188. Rozenfeld V, Pflomm JM, Singh KK et al. Assessing the impact of medication consultations
with a medication event monitoring system. Hosp Pharm. 1999;34(5):539–59.
189. Solomon DK, Portner TS, Bass GE, Gourley DR, Gourley GA, Holt JM, et al. Clinical and
economic outcomes in the hypertension and COPD arms of a multicenter outcomes study.
Journal of the American Pharmaceutical Association (Washington,D.C. : 1996).
1998;38(5):574–85.
190. Cody M, McCombs JS, Parker JP. The Kaiser Permanente/USC Patient Consultation Study:
change in quality of life. University of Southern California. American journal of health-system
pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
1998 Dec 15;55(24):2615–20.
191. Johnson KA, Parker JP, McCombs JS, Cody M. The Kaiser Permanente/USC Patient
Consultation Study: patient satisfaction with pharmaceutical services. University of Southern
California. American journal of health-system pharmacy : AJHP : official journal of the
American Society of Health-System Pharmacists. 1998 Dec 15;55(24):2621–9.
192. Sinclair HK, Bond CM, Lennox AS, Silcock J WA. Knowledge of and attitudes to smoking
cessation: the effect of stage of change training for community pharmacy staff. Health Bulletin.
1998;56:526–39.
193. Cowper PA, Weinberger M, Hanlon JT, Landsman PB, Samsa GP, Uttech KM, et al. The cost-

11. effectiveness of a clinical pharmacist intervention among elderly outpatients. Pharmacotherapy.
1998;18(2):327–32.
194. Schmidt IK, Claesson CB, Westerholm B, Nilsson LG. Physician and staff assessments of drug
interventions and outcomes in Swedish nursing homes. The Annals of pharmacotherapy. 1998
Jan;32(1):27–32.
195. Gourley DR, Gourley GA, Solomon DK, Portner TS, Bass GE, Holt JM, et al. Development,
implementation, and evaluation of a multicenter pharmaceutical care outcomes study. Journal
of the American Pharmaceutical Association (Washington,D.C. : 1996). 1998;38(5):567–73.
196. Gourley GA, Portner TSS, Gourley DR, Rigolosi EL, Holt JMM, Solomon DKK, et al.
Humanistic outcomes in the hypertension and COPD arms of a multicenter outcomes study.
Journal of the American Pharmaceutical Association (Washington,D.C. : 1996).
1998;38(5):586–97.
197. McCombs JS, Liu G, Shi J, Feng W, Cody M, Parker JP, et al. The Kaiser Permanente/USC
Patient Consultation Study: change in use and cost of health care services. American journal of
health-system pharmacy : AJHP : official journal of the American Society of Health-System
Pharmacists. 1998 Dec 1;55(23):2485–99.
198. Sinclair HK, Bond CM, Lennox a S, Silcock J, Winfield a J, Donnan PT. Training pharmacists
and pharmacy assistants in the stage-of-change model of smoking cessation: a randomised
controlled trial in Scotland. Tobacco control. 1998 Jan;7(3):253–61.
199. Kuehl AK, Chrischilles EA, Sorofman BA. System for exchanging information among
pharmacists in different practice environments. American journal of health-system pharmacy :
AJHP : official journal of the American Society of Health-System Pharmacists. 1998 May
15;55(10):1017–24.
200. Bogden PE, Abbott RD, Williamson P, Onopa JK, Koontz LM. Comparing standard care with
a physician and pharmacist team approach for uncontrolled hypertension. Journal of general
internal medicine. 1998 Nov;13(11):740–5.
201. Schmidt I, Claesson CB, Westerholm B, Nilsson LG, Svarstad BL. The impact of regular
multidisciplinary team interventions on psychotropic prescribing in Swedish nursing homes.
Journal of the American Geriatrics Society. 1998 Jan;46(1):77–82.
202. Begley S, Livingstone C, Hodges N, Williamson V, Begley S, Livingstone C, Hodges N W V.
Impact of domiciliary pharmacy visits on medication management in an elderly population.
International Journal of Pharmacy Practice. 1997 Sep 22;5(sept):111–21.
203. Bailey TC, Ritchie DJ, McMullin ST, Kahn M, Reichley RM, Casabar E, et al. A randomized,
prospective evaluation of an interventional program to discontinue intravenous antibiotics at
two tertiary care teaching institutions. Pharmacotherapy. 1997;17(2):277–81.
204. Bogden PE, Koontz LM, Williamson P, Abbott RD. The physician and pharmacist team. An
effective approach to cholesterol reduction. Journal of general internal medicine. 1997
Mar;12(3):158–64.
205. Smith L, McGowan L, Moss-Barclay C, Wheater J, Knass D, Chrystyn H. An investigation of
hospital generated pharmaceutical care when patients are discharged home from hospital.
British journal of clinical pharmacology. 1997 Aug;44(2):163–5.
206. Fraser GL, Stogsdill P, Dickens JD, Wennberg DE, Smith RP, Prato BS. Antibiotic
optimization. An evaluation of patient safety and economic outcomes. Archives of internal
medicine. 1997;157(15):1689–94.
207. Rossi RA, Every NR. A computerized intervention to decrease the use of calcium channel
blockers in hypertension. Journal of general internal medicine. 1997 Nov;12(11):672–8.
208. Gauthier I, Malone M, Lesar TS, Aronovitch S. Comparison of programs for preventing drug-
nutrient interactions in hospitalized patients. American journal of health-system pharmacy :
AJHP : official journal of the American Society of Health-System Pharmacists. 1997 Feb
15;54(4):405–11.
209. Boyko WL, Yurkowski PJ, Ivey MF, Armitstead JA, Roberts BL. Pharmacist influence on
economic and morbidity outcomes in a tertiary care teaching hospital. American journal of
health-system pharmacy : AJHP : official journal of the American Society of Health-System
Pharmacists. 1997 Jul 15;54(14):1591–5.
210. Carter BL, Barnette DJ, Chrischilles E, Mazzotti GJ, Asali ZJ. Evaluation of hypertensive
patients after care provided by community pharmacists in a rural setting. Pharmacotherapy.
1997;17(6):1274–85.
211. Park JJ, Kelly P, Carter BL, Burgess PP. Comprehensive pharmaceutical care in the chain
setting. Journal of the American Pharmaceutical Association (Washington, DC: 1996).
1996;NS36(7):443–51.

12. 212. Hanlon JT, Weinberger M, Samsa GP, Schmader KE, Uttech KM, Lewis IK, et al. A
randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate
prescribing in elderly outpatients with polypharmacy. The American journal of medicine. 1996
Apr;100(4):428–37.
213. Jaber LA, Halapy H, Fernet M, Tummalapalli S, Diwakaran H. Evaluation of a pharmaceutical
care model on diabetes management. The Annals of pharmacotherapy. 1996 Mar;30(3):238–
43.
214. Dranitsaris G, Warr D, Puodziunas A. A randomized trial of the effects of pharmacist
intervention on the cost of antiemetic therapy with ondansetron. Supportive care in cancer :
official journal of the Multinational Association of Supportive Care in Cancer. 1995
May;3(3):183–9.
215. Diwan VK, Wahlström R, Tomson G, Beermann B, Sterky G, Eriksson B. Effects of “group
detailing” on the prescribing of lipid-lowering drugs: a randomized controlled trial in Swedish
primary care. Journal of clinical epidemiology. 1995 May;48(5):705–11.
216. Razali MS, Yahya H. Compliance with treatment in schizophrenia: a drug intervention
program in a developing country. Acta psychiatrica Scandinavica. 1995 May;91(5):331–5.
217. Goodyer LI, Miskelly F, Milligan P. Does encouraging good compliance improve patients’
clinical condition in heart failure? The British journal of clinical practice. 1995;49(4):173–6.
218. Williford SL, Johnson DF. Impact of pharmacist counseling on medication knowledge and
compliance. Military medicine. 1995 Nov;160(11):561–4.
219. Jameson J, VanNoord G, Vanderwoud K. The impact of a pharmacotherapy consultation on the
cost and outcome of medical therapy. The Journal of family practice. 1995 Nov;41(5):469–72.
220. De Burgh S, Mant A, Mattick RP, Donnelly N, Hall W, Bridges-Webb C. A controlled trial of
educational visiting to improve benzodiazepine prescribing in general practice. Australian
journal of public health. 1995 Apr;19(2):142–8.
221. Van Veldhuizen-Scott MKK, Widmer LBB, Stacey SA, Popovich NGG. Developing and
implementing a pharmaceutical care model in an ambulatory care setting for patients with
diabetes. The Diabetes educator. SAGE Publications; 1995;21(2):117–23.
222. Lipton HL, Bird JA. The impact of clinical pharmacists’ consultations on geriatric patients'
compliance and medical care use: a randomized controlled trial. The Gerontologist. 1994
Jun;34(3):307–15.
223. Mungall DR, Anbe D, Forrester PL, Luoma T, Genovese R, Mahan J, et al. A prospective
randomized comparison of the accuracy of computer-assisted versus GUSTO nomogram--
directed heparin therapy. Clinical pharmacology and therapeutics. 1994 May;55(5):591–6.
224. GRYMONPRE RE, WILLIAMSON DA, HUYNH DH, DESILETS LM. A community-based
pharmaceutical care model for the elderly: report on a pilot project. International Journal of
Pharmacy Practice. 1994 Jun 22;2(4):229–34.
225. Erstad BL, Draugalis JR, Waldrop SM, Scheurer L, Namanny MD. Patients’ perceptions of
increased pharmacy contact. Pharmacotherapy. 1994;14(6):724–8.
226. Leehey DJ, Braun BI, Tholl DA, Chung LS, Gross CA, Roback JA, et al. Can pharmacokinetic
dosing decrease nephrotoxicity associated with aminoglycoside therapy. Journal of the
American Society of Nephrology : JASN. 1993 Jul;4(1):81–90.
227. Matsuyama JR, Mason BJ, Jue SG. Pharmacists’ interventions using an electronic medication-
event monitoring device's adherence data versus pill counts. The Annals of pharmacotherapy.
1993;27(7-8):851–5.
228. Raynor DK, Booth TG, Blenkinsopp A. Effects of computer generated reminder charts on
patients’ compliance with drug regimens. BMJ (Clinical research ed.). 1993 May
1;306(6886):1158–61.
229. Hurwitz B, Goodman C, Yudkin J. Prompting the clinical care of non-insulin dependent (type
II) diabetic patients in an inner city area: one model of community care. BMJ (Clinical research
ed.). 1993 Mar 6;306(6878):624–30.
230. Avorn J, Soumerai SB, Everitt DE, Ross-Degnan D, Beers MH, Sherman D, et al. A
randomized trial of a program to reduce the use of psychoactive drugs in nursing homes. The
New England journal of medicine. 1992 Jul 16;327(3):168–73.
231. Lipton HL, Bero LA, Bird JA, McPhee SJ. The impact of clinical pharmacists’ consultations
on physicians' geriatric drug prescribing. A randomized controlled trial. Medical care. 1992
Jul;30(7):646–58.
232. Broyles JE, Brown RO, Vehe KL, Nolly RJ, Luther RW. Pharmacist interventions improve
fluid balance in fluid-restricted patients requiring parenteral nutrition. The annals of
pharmacotherapy. 1991 Feb;25(2):119–22.

13. 233. Haig GM, Kiser LA. Effect of pharmacist participation on a medical team on costs, charges,
and length of stay. American journal of hospital pharmacy. 1991 Jul;48(7):1457–62.
234. Sidel VW, Beizer JL, Lisi-Fazio D, Kleinmann K, Wenston J, Thomas C, et al. Controlled
study of the impact of educational home visits by pharmacists to high-risk older patients.
Journal of community health. 1990 Jun;15(3):163–74.
235. Hawe P, Higgins G. Can medication education improve the drug compliance of the elderly?
Evaluation of an in hospital program. Patient education and counseling. 1990 Oct;16(2):151–
60.
236. Owens NJ, Sherburne NJ, Silliman RA, Fretwell MD. The Senior Care Study. The optimal use
of medications in acutely ill older patients. Journal of the American Geriatrics Society. 1990
Oct;38(10):1082–7.
237. Destache CJ, Meyer SK, Bittner MJ, Hermann KG. Impact of a clinical pharmacokinetic
service on patients treated with aminoglycosides: a cost-benefit analysis. Therapeutic drug
monitoring. 1990 Sep;12(5):419–26.
238. Steele MA, Bess DT, Franse VL, Graber SE. Cost effectiveness of two interventions for
reducing outpatient prescribing costs. The Annals of pharmacotherapy. 1989 Jun;23(6):497–
500.
239. Stergachis A, Fors M, Wagner EH, Sims DD, Penna P. Effect of clinical pharmacists on drug
prescribing in a primary-care clinic. American journal of hospital pharmacy. 1987
Mar;44(3):525–9.
240. Rubenstein LZ, Josephson K, Wieland GD, Pietruszka F, Tretton C, Strome S, et al. Geriatric
assessment on a subacute hospital ward. Clinics in geriatric medicine. 1987 Feb;3(1):131–43.
241. Williams RG, McCoy R FK. Impact of pharmacy consultant services to homebound
population. Consult Pharm. 1987;2:479–82.
242. De Tullio PL, Kirking DM, Arslanian C, Olson DE. Compliance measure development and
assessment of theophylline therapy in ambulatory patients. Journal of clinical pharmacy and
therapeutics. 1987 Feb;12(1):19–26.
243. Smith M, Murphy JE, Job ML, Ward ES. Aminoglycoside monitoring: use of a
pharmacokinetic service versus physician recommendations. Hospital formulary. 1987
Jan;22(1):92–9, 102.
244. De Tullio PL, Corson ME. Effect of pharmacist counseling on ambulatory patients’ use of
aerosolized bronchodilators. American journal of hospital pharmacy. 1987 Aug;44(8):1802–6.
245. Witte KW, Hatoum HT, Hoon TJ. Contribution of clinical pharmacists to cefazolin utilization.
Hospital formulary. 1987 Aug;22(8):737–41.
246. Johnston M, Clarke A, Mundy K, Cromarty E, Ridout K. Facilitating comprehension of
discharge medication in elderly patients. Age and ageing. 1986 Sep;15(5):304–6.
247. Simkins C V, Wenzloff NJ. Evaluation of a computerized reminder system in the enhancement
of patient medication refill compliance. Drug intelligence & clinical pharmacy. 1986
Oct;20(10):799–802.
248. Khanderia U. The cost-effectiveness of clinical pharmacist intervention on tobramycin
prescribing. Hospital formulary. 1986 Oct;21(10):1049–50, 1055–6.
249. Ascione FJ, Brown GH, Kirking DM. Evaluation of a medication refill reminder system for a
community pharmacy. Patient education and counseling. 1985 Jun;7(2):157–65.
250. McKenney JM, Witherspoon JM. The impact of outpatient hospital pharmacists on patients
receiving antihypertensive and anticoagulant therapy. Hospital pharmacy. 1985 Jun;20(6):406,
409–11, 415.
251. Baker DM. A study contrasting different modalities of medication discharge counseling.
Hospital pharmacy. 1984 Aug;19(8):545–8, 551–4.
252. Ascione FJ, Shimp LA. The effectiveness of four education strategies in the elderly. Drug
intelligence & clinical pharmacy. 1984 Nov;18(11):926–31.
253. Thompson JF, McGhan WF, Ruffalo RL, Cohen DA, Adamcik B, Segal JL. Clinical
pharmacists prescribing drug therapy in a geriatric setting: outcome of a trial. Journal of the
American Geriatrics Society. 1984 Feb;32(2):154–9.
254. Powers DA, Hamilton CW, Roberts KB. Pharmacist intervention in methadone administration
to cancer patients with chronic pain. American journal of hospital pharmacy. 1983
Sep;40(9):1520–3.
255. Self TH, Brooks JB, Lieberman P, Ryan MR. The value of demonstration and role of the
pharmacist in teaching the correct use of pressurized bronchodilators. Canadian Medical
Association journal. 1983 Jan 15;128(2):129–31.
256. Chenella FC, Klotz TA, Gill MA, Kern JW, McGhan WF, Paulson YJ, et al. Comparison of

14. physician and pharmacist management of anticoagulant therapy of inpatients. American journal
of hospital pharmacy. 1983 Oct;40(10):1642–5.
257. Avorn J, Soumerai SB. Improving drug-therapy decisions through educational outreach. A
randomized controlled trial of academically based “detailing”. The New England journal of
medicine. 1983 Jun 16;308(24):1457–63.
258. Woroniecki CL, McKercher PL, Flagler DG, Berchou R, Cook JA. Effect of pharmacist
counseling on drug information recall. American journal of hospital pharmacy. 1982
Nov;39(11):1907–10.
259. Schneider PJ, Larrimer JN, Visconti JA, Miller WA. Role effectiveness of a pharmacist in the
maintenance of patients with hypertension and congestive heart failure. Contemporary
pharmacy practice. 1982 Jan;5(2):74–9.
260. Roberts RJ, Robinson JD, Doering PL, Dallman JJ, Steeves RA. A comparison of various types
of patient instruction in the proper administration of metered inhalers. Drug intelligence &
clinical pharmacy. 1982 Jan;16(1):53–5, 59.
261. Garnett WR, Davis LJ, McKenney JM, Steiner KC. Effect of telephone follow-up on
medication compliance. American journal of hospital pharmacy. 1981 May;38(5):676–9.
262. Monson R, Bond CA, Schuna A. Role of the clinical pharmacist in improving drug therapy.
Clinical pharmacists in outpatient therapy. Archives of internal medicine. 1981
Oct;141(11):1441–4.
263. Rehder TL, McCoy LK, Blackwell B, Whitehead W, Robinson A. Improving medication
compliance by counseling and special prescription container. American journal of hospital
pharmacy. 1980 Mar;37(3):379–85.
264. Ogbuokiri JE. Self-monitoring of blood pressures in hypertensive subjects and its effects on
patient compliance. Drug intelligence & clinical pharmacy. 1980 Jun;14(6):424–7.
265. Hawkins DW, Fiedler FP, Douglas HL, Eschbach RC. Evaluation of a clinical pharmacist in
caring for hypertensive and diabetic patients. American journal of hospital pharmacy. 1979
Oct;36(10):1321–5.
266. Slama PJ, Gurwich EL. Effect of pharmacist consultation on medication compliance.
Contemporary pharmacy practice. 1978 Jan;1(2):71–7.
267. Skoutakis VA, Acchiardo SR, Martinez DR, Lorisch D, Wood GC. Role-effectiveness of the
pharmacist in the treatment of hemodialysis patients. American journal of hospital pharmacy.
1978 Jan p. 62–5.
268. McKenney JM BE. Effect of pharmacist drug monitoring and patient education on
hypertensive patients. Contemp Pharm Pract. 1978;1:50–6.
269. MacDonald ET, MacDonald JB, Phoenix M. Improving drug compliance after hospital
discharge. British medical journal. 1977 Sep 3;2(6087):618–21.
270. Sczupak CA, Conrad WF. Relationship between patient-oriented pharmaceutical services and
therapeutic outcomes of ambulatory patients with diabetes mellitus. American journal of
hospital pharmacy. 1977 Nov;34(11):1238–42.
271. Soflin D, Young WW, Clayton BD. Development and evaluation of an individualized patient
education program about digoxin. American journal of hospital pharmacy. 1977
Apr;34(4):367–71.
272. Chubb JM WH. The pharmacist’s role in preventing medication errors made by cardiac and
hyperlipoproteinemic outpatients. Drug Intell Clin Pharm. 1974;8(July):430–6.
273. McKenney JM, Slining JM, Henderson HR, Devins D, Barr M. The effect of clinical pharmacy
services on patients with essential hypertension. Circulation. 1973 Nov;48(5):1104–11.